ANTIHISTAMINES IN THE TREATMENT OF COLD-RELATED DISEASES IN CHILDREN
https://doi.org/10.15690/vsp.v14i2.1299
Abstract
The article is devoted to the relevant problem of pediatrics - treatment of acute respiratory infections in children. It examines the feasibility of a comprehensive treatment of colds in children with mandatory use of non-sedating antihistamines that increase the effectiveness of conventional treatment and prevent the development of allergic complications.
About the Author
O. B. Tamrazova
Peoples' Friendship University of Russia, Moscow, Russian Federation
Russian Federation
Russian Federation
References
1. Pochivalov A.V., Pogorelova E.I. Treatment of acute respiratory viral infections in children with atopic dermatitis. Consilium medicum (prilozhenie «Pediatriya») = Consilium medicum (Supplement "Pediatrics"). 2010; 1: 69–70.
2. Ivanov V.A., Sharapov V.A., Zaplatnikov A.L. The state of health of frequently ill children and improve the efficiency of sanatorium rehabilitation. Russkii meditsinskii zhurnal = Russian medical journal. 2007; 15 (21): 1559–1566.
3. Korovina N.A., Zaplatnikov A.L., Cheburkin A.V., Zakharova I.N. Chasto i dlitel'no boleyushchie deti: sovremennye vozmozhnosti immunoreabilitatsii [RRI Children: Immunorehabilitation Advanced Features]. Moscow, Kontimed, 2001. 68 p.
4. Al'bitskii V.Yu., Baranov A.A., Kamaev I.A. Chasto boleyushchie deti [RRI Children]. Nizhny Novgorod, 2003. 174 p.
5. Ostrye respiratornye zabolevaniya u detei: lechenie i profilaktika. Nauch.-prakt. progr. Soyuza pediatrov Rossii [ARI in Children: Treatment and Prevention. Scientific and Practical Conference of the Union of Pediatricians of Russia]. Moscow, Mezhdunarodnyi Fond okhrany zdorov'ya materi i rebenka, 2002. 69 p.
6. Sovremennye podkhody k lecheniyu i reabilitatsii chasto boleyushchikh detei. Pos. dlya vrachei. Pod red. L.S. Balevoi, N.A. Korovinoi, V.K. Tatochenko [Current approaches to the treatment and rehabilitation of sickly children. Pos. for physicians. Ed. LS Balewa, NA Korovina, VK Tatochenko]. Moscow, Agentstvo Meditsinskogo marketinga, 2006. 56 p.
7. Mossad S.B. Upper Respiratory Tract Cleveland Clinic. Department of Infectious Disease. Available at: www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/infectiousdisease/urti/urti1.htm (accessd: 06.12.2008).
8. Wessels M.R. Clinical practice: streptococcal pharyngitis. N. Engl. J. Med. 2011; 364: 648–655.
9. Wilson J.F. In the clinic: acute sinusitis. Ann. Intern. Med. 2010; 153: 2–14.
10. Vuorinen T., Vainionpää R., Hyypiä T. Five years’ experience of reverse-transcriptase polymerase chain reaction in daily diagnosis of enterovirus and rhinovirus infections. Clin. Infect. Dis. 2003; 37: 452–455.
11. Fine A.M., Nizet V., Mandl K.D. Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis. Arch. Intern. Med. 2012; 172: 847–852.
12. Yartsev M.N., Yakovleva K.P., Plakhtienko M.V. Immune deficiency and RRI children. Consilium medicum (prilozhenie «Pediatriya») = Consilium medicum (Supplement "Pediatrics"). 2006; 1: 13–18.
13. Torshkoeva L.B., Glukhareva N.S., Zaplatnikov A.L. Treatment of acute respiratory viral infections in children. Russkii meditsinskii zhurnal = Russian medical journal. 2010; 20: 1237–1242
14. Tamrazova O.B., Molochkov A.V. Conjunctival skin - the main pathogenic factor in the development of atopic dermatitis. Consilium medicum (prilozhenie «Dermatologiya») = Consilium medicum (Supplement "Dermatology"). 2014; 4: 48–54.
15. Zutavern A., von Klot S., Gehring U., Krauss-Etschmann S., Heinrich J. Pre-natal and post-natal exposure to respiratory infection and atopic diseases development: a historical cohort study. Respir. Res. 2006; 23 (7): 81.
16. Kilpi T., Kero J., Jokinen J., Syrjänen R., Takala A.K., Hovi T., Isolauri E. Common respiratory infections early in life may reduce the risk of atopic dermatitis. Clin. Infect. Dis. 2002; 34 (5): 620–626.
17. Heymann P.W., Carper H.T., Murphy D.D., Platts-Mills T.A., Patrie J., McLaughlin A.P., Erwin E.A., Shaker M.S., Hellems M., Peerzada J., Hayden F.G., Hatley T.K., Chamberlain R. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J. Allergy Clin. Immunol. 2004; 114: 239–247.
18. Ciprandi G., Tosca MA, Fasce L. Allergic children have more numerous and severe respiratory infections than non-allergic children. Pediatr. Allergy Immunol. 2006; 17 (5): 389–391.
19. Cirillo I., Marseglia G., Klersy C., Ciprandi G. Allergic patients have more numerous and prolonged respiratory infections than nonallergic subjects. Allergy. 2007; 62 (9): 1087–1090.
20. Jung J.A., Kita H., Yawn B.P., Boyce T.G., Yoo K.H. Increased risk of serious pneumococcal disease in patients with atopic conditions other than asthma. J. Allergy Clin. Immunol. 2010; 125 (1): 217–221.
21. Wark P.A., Johnston S.L., Bucchieri F., Powell R., Puddicombe S., Laza-Stanca V., Holgate S.T., Davies D.E. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 2005; 201 (6): 937–947.
22. Contoli M., Message S.D., Laza-Stanca V., Edwards M.R., Wark P.A., Bartlett N.W., Kebadze T., Mallia P., Stanciu L.A., Parker H.L. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat. Med. 2006; 12 (9): 1023–1026.
23. Zaitseva O.V. Acute respiratory infections in patients with allergies. Lechashchii vrach = Practicing doctor. 2006; 9: 28–32.
24. Simon F.E.R., Simons K.J. H1 Antihistamines: Current Status and Future Directions. World Allergy Organ J. 2008; 1 (9): 145–155.
25. Akdis C.A., Simons F.E.R. Histamine receptors are hot in immunopharmacology. Eur. J. Pharmacol. 2006; 1: 69–76.
26. Simons F.E.R. Advances in H 1-antihistamines. N. Engl. J. Med. 2004; 1: 2203–2217.
27. Fourneau E., Bovet D. Recherches sur l'action sympathicolytique d'un nouveau dérivé du dioxane. Archives Internationales de Pharmacodynamie et de Thérapie. 1933; 46: 178–191.
28. Simons F.E.R., Akdis C.A., Adkinson N.F., Jr., Yunginger J.W., Busse W.W., Bochner B.S., Holgate S.T., Lemanske R.FHistamine and antihistamines. In: Middleton's allergy principles and practice. F.E.R. Simons (ed.). St. Louis, MO: Mosby Inc. (an affiliate of Elsevier Science). 2008. P. 1517–1547.
29. Holgate S.T., Canonica G.W., Simons F.E.R., Taglialatela M., Tharp M., Timmerman H., Yanai K. Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations. Clin. Exp. Allergy. 2003; 1: 1305–1324.
30. Simons F.E.R. H 1-antihistamines in childrenIn: Histamine and H1-antihistamines in allergic disease. F.E.R. Simons (ed.). New York: Marcel Dekker Inc. 2002. P. 437–464.
31. Golightly L.K., Greos L.S. Second-generation antihistamines: actions and efficacy in the management of allergic disorders. Drugs. 2005; 1: 341–384.
32. Scharman E.J., Erdman A.R., Wax P.M., Chyka P.A., Caravati E.M. Diphenhydramine and dimenhydrinate poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin. Toxicol. (Phila). 2006; 1: 205–223.
33. Fedoskova T.G. Features of patients with perennial allergic rhinitis acute respiratory viral infections. Russkii meditsinskii zhurnal = Russian medical journal. 2011; 19 (8): 518–521.
34. Irwin R.S., Baumann M.H., Bolser D.C., Boulet L.P., Braman S.S., Brightling C.E. For the American College of Chest Physicians. Diagnosis and management of cough: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129 (Suppl. 1): 4.
35. Sutter A.I., Lemiengre M., Campbell H., Mackinnon H.F. Antihistamines for the common cold. Cochr. Database Syst. Rev. 2003; 3: CD001267.
36. Sutter A.I., Lemiengre M., Campbell H. WITHDRAWN: Antihistamines for the common cold. Cochr. Database Syst. Rev. 2009; 4: CD001267.
37. Sutter A.I., van Driel M.L., Kumar A.A., Lesslar O., Skrt A. Oral antihistamine-decongestant-analgesic combinations for the common cold. Cochr. Database Syst. Rev. 2012; 2: CD004976.
38. Murdoch D., Goa K.L., Keam S.J. Desloratadine: an update of its efficacy in the management of allergic disorders. Drugs. 2003; 1: 2051–2077.
39. Bachert С., Keith P., Joaquim M.J. Desloratadine significantly reduces nasal congestion and other individual symptoms scores in subjects with intermittent allergic rhinitis: the ACCEPT1 study in collaboration with GA2LEN. Abstract #1760 EAACI 2008. Barcelona, Spain. 2008.
40. Bloom M., Staudinger H., Herron J. Safety of desloratadine syrup in children. Curr. Med. Res. Opin. 2004; 20 (12): 1959-1965.
41. Prenner B., Ballona R., Bueso A. et al. Safety of desloratadine syrup in children six months to younger than 2 years of age: a randomized, double-blinded, placebo-controlled study. Pediatr. Asthma Allergy & Immunol. 2006; 19 (2): 91–99.
42. Gupta S.K., Kantesari B., Banfield C., Wang Z. Desloratadine dose selection in children aged 6 months to 2 years: comparison of population pharmacokinetics between children and adults. Brit. J. Clin. Pharmacol. 2007; 64 (2): 174–184.
43. Nagornaya N.V., Bordyugova E.V., Lebedeva A.V. Desloratadine in the treatment of atopic dermatitis in children. Zdorov’ya Ukraini = Health of Ukraine. 2011; 1 (13): 44–45.
Review
For citations:
Tamrazova O.B. ANTIHISTAMINES IN THE TREATMENT OF COLD-RELATED DISEASES IN CHILDREN. Current Pediatrics. 2015;14(2):281-286. (In Russ.) https://doi.org/10.15690/vsp.v14i2.1299
Views:
1355
Email this article 
